198 related articles for article (PubMed ID: 38803222)
1. Full-length MSP1 is a major target of protective immunity after controlled human malaria infection.
Rosenkranz M; Nkumama IN; Ogwang R; Kraker S; Blickling M; Mwai K; Odera D; Tuju J; Fürle K; Frank R; Chepsat E; Kapulu MC; Study Team CS; Osier FH
Life Sci Alliance; 2024 Aug; 7(8):. PubMed ID: 38803222
[TBL] [Abstract][Full Text] [Related]
2. Merozoite Surface Protein 1 from Plasmodium falciparum Is a Major Target of Opsonizing Antibodies in Individuals with Acquired Immunity against Malaria.
Jäschke A; Coulibaly B; Remarque EJ; Bujard H; Epp C
Clin Vaccine Immunol; 2017 Nov; 24(11):. PubMed ID: 28877929
[TBL] [Abstract][Full Text] [Related]
3. Immunity to recombinant plasmodium falciparum merozoite surface protein 1 (MSP1): protection in Aotus nancymai monkeys strongly correlates with anti-MSP1 antibody titer and in vitro parasite-inhibitory activity.
Singh S; Miura K; Zhou H; Muratova O; Keegan B; Miles A; Martin LB; Saul AJ; Miller LH; Long CA
Infect Immun; 2006 Aug; 74(8):4573-80. PubMed ID: 16861644
[TBL] [Abstract][Full Text] [Related]
4. Breadth of Functional Antibodies Is Associated With Plasmodium falciparum Merozoite Phagocytosis and Protection Against Febrile Malaria.
Kana IH; Singh SK; Garcia-Senosiain A; Dodoo D; Singh S; Adu B; Theisen M
J Infect Dis; 2019 Jun; 220(2):275-284. PubMed ID: 30820557
[TBL] [Abstract][Full Text] [Related]
5. Immunoglobulin G subclass-specific responses against Plasmodium falciparum merozoite antigens are associated with control of parasitemia and protection from symptomatic illness.
Stanisic DI; Richards JS; McCallum FJ; Michon P; King CL; Schoepflin S; Gilson PR; Murphy VJ; Anders RF; Mueller I; Beeson JG
Infect Immun; 2009 Mar; 77(3):1165-74. PubMed ID: 19139189
[TBL] [Abstract][Full Text] [Related]
6. Association of antibodies to Plasmodium falciparum merozoite surface protein-4 with protection against clinical malaria.
Perraut R; Varela ML; Joos C; Diouf B; Sokhna C; Mbengue B; Tall A; Loucoubar C; Touré A; Mercereau-Puijalon O
Vaccine; 2017 Dec; 35(48 Pt B):6720-6726. PubMed ID: 29042203
[TBL] [Abstract][Full Text] [Related]
7. Human antibodies fix complement to inhibit Plasmodium falciparum invasion of erythrocytes and are associated with protection against malaria.
Boyle MJ; Reiling L; Feng G; Langer C; Osier FH; Aspeling-Jones H; Cheng YS; Stubbs J; Tetteh KK; Conway DJ; McCarthy JS; Muller I; Marsh K; Anders RF; Beeson JG
Immunity; 2015 Mar; 42(3):580-90. PubMed ID: 25786180
[TBL] [Abstract][Full Text] [Related]
8. Opsonic phagocytosis of Plasmodium falciparum merozoites: mechanism in human immunity and a correlate of protection against malaria.
Osier FH; Feng G; Boyle MJ; Langer C; Zhou J; Richards JS; McCallum FJ; Reiling L; Jaworowski A; Anders RF; Marsh K; Beeson JG
BMC Med; 2014 Jul; 12():108. PubMed ID: 24980799
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of erythrocyte invasion and Plasmodium falciparum merozoite surface protein 1 processing by human immunoglobulin G1 (IgG1) and IgG3 antibodies.
Lazarou M; Guevara Patiño JA; Jennings RM; McIntosh RS; Shi J; Howell S; Cullen E; Jones T; Adame-Gallegos JR; Chappel JA; McBride JS; Blackman MJ; Holder AA; Pleass RJ
Infect Immun; 2009 Dec; 77(12):5659-67. PubMed ID: 19805526
[TBL] [Abstract][Full Text] [Related]
10. The quantity and quality of African children's IgG responses to merozoite surface antigens reflect protection against Plasmodium falciparum malaria.
Courtin D; Oesterholt M; Huismans H; Kusi K; Milet J; Badaut C; Gaye O; Roeffen W; Remarque EJ; Sauerwein R; Garcia A; Luty AJ
PLoS One; 2009 Oct; 4(10):e7590. PubMed ID: 19859562
[TBL] [Abstract][Full Text] [Related]
11. Plasmodium falciparum MSP3 Exists in a Complex on the Merozoite Surface and Generates Antibody Response during Natural Infection.
Deshmukh A; Chourasia BK; Mehrotra S; Kana IH; Paul G; Panda A; Kaur I; Singh SK; Rathore S; Das A; Gupta P; Kalamuddin M; Gakhar SK; Mohmmed A; Theisen M; Malhotra P
Infect Immun; 2018 Aug; 86(8):. PubMed ID: 29760216
[No Abstract] [Full Text] [Related]
12. Malaria parasite-inhibitory antibody epitopes on Plasmodium falciparum merozoite surface protein-1(19) mapped by TROSY NMR.
Morgan WD; Lock MJ; Frenkiel TA; Grainger M; Holder AA
Mol Biochem Parasitol; 2004 Nov; 138(1):29-36. PubMed ID: 15500913
[TBL] [Abstract][Full Text] [Related]
13. Long-lived Plasmodium falciparum specific memory B cells in naturally exposed Swedish travelers.
Ndungu FM; Lundblom K; Rono J; Illingworth J; Eriksson S; Färnert A
Eur J Immunol; 2013 Nov; 43(11):2919-29. PubMed ID: 23881859
[TBL] [Abstract][Full Text] [Related]
14. Allele specificity of gamma interferon responses to the carboxyl-terminal region of Plasmodium falciparum merozoite surface protein 1 by Kenyan adults with naturally acquired immunity to malaria.
Spring MD; Chelimo K; Tisch DJ; Sumba PO; Rochford R; Long CA; Kazura JW; Moormann AM
Infect Immun; 2010 Oct; 78(10):4431-41. PubMed ID: 20696832
[TBL] [Abstract][Full Text] [Related]
15. Patterns of protective associations differ for antibodies to P. falciparum-infected erythrocytes and merozoites in immunity against malaria in children.
Chan JA; Stanisic DI; Duffy MF; Robinson LJ; Lin E; Kazura JW; King CL; Siba PM; Fowkes FJ; Mueller I; Beeson JG
Eur J Immunol; 2017 Dec; 47(12):2124-2136. PubMed ID: 28833064
[TBL] [Abstract][Full Text] [Related]
16. Merozoite Antigens of Plasmodium falciparum Elicit Strain-Transcending Opsonizing Immunity.
Hill DL; Wilson DW; Sampaio NG; Eriksson EM; Ryg-Cornejo V; Harrison GLA; Uboldi AD; Robinson LJ; Beeson JG; Siba P; Cowman AF; Hansen DS; Mueller I; Schofield L
Infect Immun; 2016 Aug; 84(8):2175-2184. PubMed ID: 27185785
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to Plasmodium falciparum merozoite surface protein-1p19 malaria vaccine candidate induce antibody-dependent respiratory burst in human neutrophils.
Joos C; Varela ML; Mbengue B; Mansourou A; Marrama L; Sokhna C; Tall A; Trape JF; Touré A; Mercereau-Puijalon O; Perraut R
Malar J; 2015 Oct; 14():409. PubMed ID: 26471813
[TBL] [Abstract][Full Text] [Related]
18. Targets of complement-fixing antibodies in protective immunity against malaria in children.
Reiling L; Boyle MJ; White MT; Wilson DW; Feng G; Weaver R; Opi DH; Persson KEM; Richards JS; Siba PM; Fowkes FJI; Takashima E; Tsuboi T; Mueller I; Beeson JG
Nat Commun; 2019 Feb; 10(1):610. PubMed ID: 30723225
[TBL] [Abstract][Full Text] [Related]
19. Quantifying the importance of MSP1-19 as a target of growth-inhibitory and protective antibodies against Plasmodium falciparum in humans.
Wilson DW; Fowkes FJ; Gilson PR; Elliott SR; Tavul L; Michon P; Dabod E; Siba PM; Mueller I; Crabb BS; Beeson JG
PLoS One; 2011; 6(11):e27705. PubMed ID: 22110733
[TBL] [Abstract][Full Text] [Related]
20. Bi-isotype immunoglobulins enhance antibody-mediated neutrophil activity against
Ogwang R; Murugu L; Nkumama IN; Nyamako L; Kai O; Mwai K; Murungi L; Idro R; Bejon P; Tuju J; Kinyanjui SM; Osier FHA
Front Immunol; 2024; 15():1360220. PubMed ID: 38650925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
